Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S3 from Febuxostat Enhances the Antitumor Efficacy of 2-Fluoroadenine and 5′-Methylthioadenosine in MTAP-Deleted Cancer
  1. Home
  2. Publications
  3. Figure S3 from Febuxostat Enhances the Antitumor Efficacy of 2-Fluoroadenine and 5′-Methylthioadenosine in MTAP-Deleted Cancer

Figure S3 from Febuxostat Enhances the Antitumor Efficacy of 2-Fluoroadenine and 5′-Methylthioadenosine in MTAP-Deleted Cancer

Authors:
  • BTBaiqing Tang
    Baiqing Tang
  • HLHyung-Ok Lee
    Hyung-Ok Lee
  • DKDaniel Krzizike
    Daniel Krzizike
  • KCKathy Q. Cai
    Kathy Q. Cai
  • SGSapna Gupta
    Sapna Gupta
  • WKWarren D. Kruger
    Warren D. Kruger

Open Access
Publisher website
Google Scholar
  • 14 August 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.33254318
Abstract
Supplemental Figure 3. Weight loss and toxicity of HT1080 SCID mice.
Keywords
  • FEBUXOSTAT ENHANCES
  • ANTITUMOR EFFICACY
  • CANCER SUPPLEMENTAL
  • SUPPLEMENTAL FIGURE
  • MTAP-DELETED CANCER
  • FIGURE
  • SCID MICE
  • FEBUXOSTAT
  • ENHANCES
  • ANTITUMOR
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.